Gastro intestinal and HPB (hepato pancreato biliary) cancers are rising at an alarming pace in India, Deputy Director of Tata Memorial Hospital Dr. Shailesh V. Shrikhande has said.
“Surgery remains the most definitive mode of treatment for many of these cases. The ‘HPB and GI Cancer Surgery Summit-2025’ focuses on surgical precision, oncological safety, and preparing the next generation of specialists to handle the increasing burden with skill and innovation,” he said while speaking at the summit.
Dr Adarsh Chaudhary, chairman, Department of GI Surgery, Medanta Medicity, Gurugram, noted, “Upper GI cancers continue to present some of the toughest challenges in oncologic surgery. Scientific meetings like this are essential to refine our approach and ensure the best possible outcomes for patients.”
The Summit 2025, organised by the Senadhipan Education Foundation, marks the Foundation’s first international physical conclave, drawing over 400 gastrointestinal and HPB surgery professionals from across India and abroad.
Despite travel challenges, the participation of leading clinicians, both physically and virtually, underscores the global commitment to advancing cancer care.
“This summit reflects a decade of work in building a serious academic forum,” said Dr. Baiju Senadhipan, organising secretary.
Prominent surgeons are leading discussions on key concerns in upper GI and HPB cancers. Topics include the role of rehabilitation in surgical outcomes, advances in resection strategies, and management of complications in oesophageal and gastric cancers.
The academic committee has curated a program that balances scientific depth with clinical relevance.
Global voices such as Prof Tsuyoshi Etoh (Oita University, Japan) and Prof Guido Torzilli, Humanitas University, Italy, are contributing through virtual sessions.
UNI DS PRS
